Senate Holds Hearing on Artificial Technology and Health Care
The Senate Health, Education, Labor and Pensions Subcommittee
on Primary Health and Retirement Security held a hearing on policy considerations for artificial intelligence
(AI) in health care. Testifying at the hearing were Dr. Keith Sale, Vice President
and Chief Physician Executive of Ambulatory Services at the University of Kansas
Health System; Dr. Kenneth Mandl, Director of the Computational Health Informatics
Program at Boston Children’s Hospital; Dr. Thomas Inglesby, Director of the
Johns Hopkins Center for Health Security; and Ms. Christine Huberty, Supervising
Attorney for the Greater Wisconsin Agency on Aging Resources.
Much of the testimony focused on the benefits AI had for the health sector, including
cutting down clinicians’ administrative work, allowing clinicians to access
and analyze data they couldn’t on their own, reducing health care costs and accelerating drug discovery.
But the technology may need guardrails to function safely
and effectively—or AI could cause harm to patients or exacerbate existing inequities,
which was a concern expressed by U.S. Rep. Ben Ray Lujan (D-NM). Citing a 2020
Journal of the American Medical Association study, U.S. Rep. Lujan noted
that the study found that deep learning algorithms, incorporated into certain
AI platforms, were disproportionately trained using U.S. patient data from California,
Massachusetts and New York with little representation from the rest of the country.
The disproportionate use of the regional data calls into question whether AI will
improve health outcomes and reduce health disparities for all Americans or only
for those in certain parts of the country.